| Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection JFS Mann, E Shakir, KC Carter, AB Mullen, J Alexander, VA Ferro Vaccine 27 (27), 3643-3649, 2009 | 191 | 2009 |
| Delivery systems: a vaccine strategy for overcoming mucosal tolerance? JFS Mann, R Acevedo, J Campo, O Pérez, VA Ferro Expert review of vaccines 8 (1), 103-112, 2009 | 114 | 2009 |
| The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment HP Oswin, AE Haddrell, M Otero-Fernandez, JFS Mann, TA Cogan, ... Proceedings of the National Academy of Sciences 119 (27), e2200109119, 2022 | 111 | 2022 |
| Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity JFS Mann, HE Scales, E Shakir, J Alexander, KC Carter, AB Mullen, ... Methods 38 (2), 90-95, 2006 | 100 | 2006 |
| Advances in HIV-1 vaccine development Y Gao, PF McKay, JFS Mann Viruses 10 (4), 167, 2018 | 89 | 2018 |
| Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin JFS Mann, VA Ferro, AB Mullen, L Tetley, M Mullen, KC Carter, ... Vaccine 22 (19), 2425-2429, 2004 | 89 | 2004 |
| Virus-like particle, liposome, and polymeric particle-based vaccines against HIV-1 Y Gao, C Wijewardhana, JFS Mann Frontiers in Immunology 9, 335645, 2018 | 75 | 2018 |
| Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection JFS Mann, PF McKay, S Arokiasamy, RK Patel, K Klein, RJ Shattock Journal of controlled release 170 (3), 452-459, 2013 | 44 | 2013 |
| Immune responses to a GnRH-based anti-fertility immunogen, induced by different adjuvants and subsequent effect on vaccine efficacy VA Ferro, R Costa, KC Carter, MJA Harvey, MM Waterston, AB Mullen, ... Vaccine 22 (8), 1024-1031, 2004 | 43 | 2004 |
| Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes JFS Mann, PF McKay, A Fiserova, K Klein, A Cope, P Rogers, J Swales, ... Journal of virology 88 (12), 6959-6969, 2014 | 38 | 2014 |
| Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen PF McKay, AV Cope, JFS Mann, S Joseph, M Esteban, R Tatoud, D Carter, ... PloS one 9 (1), e84707, 2014 | 37 | 2014 |
| First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses E Choi, CJ Michalski, SH Choo, GN Kim, E Banasikowska, S Lee, K Wu, ... Retrovirology 13, 1-16, 2016 | 36 | 2016 |
| Addressing an HIV cure in LMIC SD Ismail, J Pankrac, E Ndashimye, JL Prodger, MR Abrahams, ... Retrovirology 18 (1), 21, 2021 | 35 | 2021 |
| TLR4 and TLR7/8 adjuvant combinations generate different vaccine antigen-specific immune outcomes in minipigs when administered via the ID or IN routes PF McKay, DFL King, JFS Mann, G Barinaga, D Carter, RJ Shattock PloS one 11 (2), e0148984, 2016 | 32 | 2016 |
| Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses PF McKay, JFS Mann, A Pattani, V Kett, Y Aldon, D King, RK Malcolm, ... Journal of Controlled Release 249, 74-83, 2017 | 30 | 2017 |
| Eradication of HIV-1 latent reservoirs through therapeutic vaccination J Pankrac, K Klein, JFS Mann AIDS research and therapy 14, 1-4, 2017 | 28 | 2017 |
| A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system J Pankrac, K Klein, PF McKay, DFL King, K Bain, J Knapp, T Biru, ... NPJ vaccines 3 (1), 2, 2018 | 22 | 2018 |
| Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines K Klein, JFS Mann, P Rogers, RJ Shattock Journal of controlled release 183, 43-50, 2014 | 22 | 2014 |
| Measuring stability of virus in aerosols under varying environmental conditions HP Oswin, AE Haddrell, M Otero-Fernandez, TA Cogan, JFS Mann, ... Aerosol Science and Technology 55 (12), 1315-1320, 2021 | 21 | 2021 |
| Mucosal application of gp140 encoding DNA polyplexes to different tissues results in altered immunological outcomes in mice JFS Mann, PF McKay, S Arokiasamy, RK Patel, JS Tregoning, ... PloS one 8 (6), e67412, 2013 | 19 | 2013 |
